Presence of UDP-N-Acetylmuramyl-Hexapeptides and -Heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin

Journal of Bacteriology

Volumn 179, Issue 15, 1997, Pages 4684-4688

  Billot Klein, D ^a   Shlaes, D ^b   Bryant, D ^c   Bell, D ^c   Legrand, R ^d   Gutmann, L ^a   Van Heijenoort, J ^e  

^a SORBONNE UNIVERSITÉ   (France)

^b PFIZER INC   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d SANOFI   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPTAPEPTIDE; HEXAPEPTIDE; PENTAPEPTIDE; PEPTIDOGLYCAN; RAMOPLANIN; TUNICAMYCIN; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STAPHYLOCOCCUS;

ENTEROCOCCUS; STAPHYLOCOCCI; STAPHYLOCOCCUS;

EID: 0030741917     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.179.15.4684-4688.1997     Document Type: Article

References (31)

1. Allen, N. E., J. N. Hobbs, Jr., J. M. Richardson, and R. M. Riggin. 1992. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol. Lett. 98:109-116.
2. Al-Obeid, S., L. Gutmann, D. M. Shlaes, R. Willamson, and E. Collatz. 1990. Comparison of vancomycin-inducible proteins from four strains of enterococci. FEMS Microbiol. Lett. 70:101-106.
3. Arthur, M., P. Reynolds, and P. Courvalin. 1996. Glycopeptide resistance in enterococci. Trends Microbiol. 4:401-407.
4. Billot-Klein, D., L. Gutmann, E. Collatz, and J. van Heijenoort. 1992. Analysis of peptidoglycan precursors in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 36:1487-1490.
5. Billot-Klein, D., L. Gutmann, S. Sablé, E. Guittet, and J. van Heijenoort. 1994. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type emerococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J. Bacteriol. 176:2398-2405.
6. Billot-Klein, D., D. Shlaes, D. Bryant, D. Bell, J. van Heijenoort, and L. Gutmann. 1996. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VANB-type. Biochem. J. 313:711-715.
7. Billot-Klein, D., L. Gutmann, D. Bryant, D. Bell, J. van Heijenoort, J. Grewal, and D. M. Shlaes. 1996. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J. Bacteriol. 178:4696-4703.
8. Ciabatti, R., J. K. Kettening, G. Winters, G. Tuan, L. Zerilli, and B. Cavalleri. 1989. Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation. J. Antibiot. 42:254-267.
9. De Jonge, B. L. M., Y. S. Chang, D. Gage, and A. Tomasz. 1992. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin-binding protein 2A. J. Biol. Chem. 267:11248-11254.
10. De Jonge, B. L. M., T. Sidow, Y.-S. Chang, H. Labischinski, B. Berger-Bachi, D. A. Gage, and A. Tomasz. 1993. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J. Bacteriol. 175:2779-2782.
11. Gutmann, L., D. Billot-Klein, S. Al-Obeid, I. Klare, S. Francoual, E. Collatz, and J. van Heijenoort. 1992. Inducible carboxypeptidase activity in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 36:77-80.
12. Handwerger, S., M. J. Pucci. K. J. Volk, J. Liu, and M. S. Lee. 1992. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J. Bacteriol. 174:5982-5984.
13. Handwerger, S., M. J. Pucci, K. J. Volk, J. Liu, and M. S. Lee. 1994. Vancomycin-resislant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J. Bacteriol. 176:260-264.
14. Herwaldt, L., L. Boyken, and M. Pfaller. 1991. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcia hemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 10:1007-1012.
15. Kaatz, G. W., S. M. Seo, M. J. Dorman, and S. A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
16. Mandelstam, P., R. Loercher, and J. L. Strominger. 1992. A uridine diphosphoacetylmuramylhexapeptide from penicillin-treated Streptococcus faecalis. J. Biol. Chem. 237:2683-2688.
17. Matsuhashi, M., C. P. Dietrich, and J. Strominger. 1965. Incorporation of glycine into the cell wall glycopeptide in Staphylococcus aureus: role of sRNA and lipid intermediates. Proc. Natl. Acad. Sci. USA 54:587-594.
18. Matsuhashi, M., C. P. Dietrich, and J. L. Strominger. 1967. Biosynthesis of the peptidoglycan of bacterial cell walls. III. The role of soluble ribonucleic acid and of lipid intermediate in glycine incorporation in Staphylococcus aureus. J. Biol. Chem. 242:3191-3206.
19. Mengin-Lecreulx, D., B. Flouret, and J. van Heijenoort. 1982. Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli. J. Bacteriol. 151:1109-1117.
20. Mengin-Lecreulx, D., B. Flouret, and J. van Heijenoort. 1983. Pool levels of UDP-N-acetylglucosamine and UDP-N-acetylglucosamine-enolpyruvate in Escherichia coli and correlation with peptidoglycan synthesis. J. Bacteriol. 154:1284-1290.
21. Messer, J., and P. E. Reynolds. 1992. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol. Lett. 94: 195-200.
22. Pallanza, R., M. Berti, R. Scotti, E. Randisi, and V. Arioli. 1984. A-16686, a new antibiotic from Actinoplanes. II. Biological properties. J. Antibiot. 37: 318-324.
23. Plapp, R., and J. Strominger. 1970. Biosynthesis of the peptidoglycan of bacterial cell walls. XVII. Biosynthesis of peptidoglycan and of interpeptide bridges in Lactobacillus viridescens. J. Biol. Chem. 245:3667-3674.
24. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
25. Rogers, H. J., H. R. Perkins, and J. B. Ward. 1980. Microbial cell walls and membranes. Chapman & Hall Ltd., London, United Kingdom.
26. Rosato, A., J. Pierre, D. Billot-Klein, A. Buu-Hoi, and L. Gutmann. 1995. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob. Agents Chemother. 39:830-833.
27. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
28. Sommer, E. A., and P. E. Reynolds. 1990. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother. 34:413-419.
29. Staudenbauer, W., and J. L. Strominger. 1972. Activation of D-aspartic acid for incorporation into peptidoglycan. J. Biol. Chem. 247:5095-5102.
30. ε-Ala-Lys moiety into the peptide subunit of nascent peptidoglycan. J. Bacteriol. 125:626-634.
31. van Heijenoort, J. 1994. Biosynthesis of the peptidoglycan unit, p. 39-54. In J. M. Ghuysen and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B.V., Amsterdam, The Netherlands.